BamSEC and AlphaSense Join Forces
Learn More

Ambrx Inc

Formerly NASDAQ: AMBX
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.32
from S-1/A 58 pages Certain Material (Indicated by an Asterisk) Has Been Omitted From This Document Pursuant to a Request for Confidential Treatment. the Omitted Material Has Been Filed Separately With the Securities and Exchange Commission. Co-Development and License Agreement Between Zhejiang Hisun Pharmaceutical Co., Ltd. and Ambrx, Inc. Dated as of April 10, 2014 Co-Development and License Agreement
12/34/56
EX-10.27
from S-1/A 16 pages Introduction
12/34/56
EX-10.22
from S-1/A 58 pages Introduction
12/34/56
EX-10.21
from S-1/A 89 pages Certain Material (Indicated by an Asterisk) Has Been Omitted From This Document Pursuant to a Request for Confidential Treatment. the Omitted Material Has Been Filed Separately With the Securities and Exchange Commission. Co-Development and License Agreement Between Zhejiang Medical Corporation and Ambrx, Inc. Dated as of June 14, 2013 Co-Development and License Agreement
12/34/56
EX-10.16
from S-1/A 71 pages Research Collaboration, Option and Exclusive License Agreement by and Between Merck Sharp & Dohme Corp. and Ambrx, Inc. Research Collaboration, Option and Exclusive License Agreement
12/34/56
EX-10.15
from S-1/A 110 pages Recitals 1. Definitions
12/34/56
EX-10.14
from S-1/A 115 pages 1. Definitions
12/34/56
EX-10.13
from S-1/A 103 pages 1. Definitions
12/34/56
EX-10.40
from S-1/A 3 pages Second Amendment to Severance and Change in Control Agreement
12/34/56
EX-10.39
from S-1/A 3 pages Third Amendment to Executive Employment Agreement
12/34/56
EX-10.38
from S-1/A 3 pages Amendment to Executive Employment Agreement
12/34/56
EX-10.37
from S-1/A 3 pages Amendment to Executive Employment Agreement
12/34/56
EX-10.36
from S-1/A 6 pages Amendment to Executive Employment Agreement
12/34/56
EX-10.35
from S-1/A 2 pages Amendment to the Ambrx, Inc. 2013 Equity Incentive Plan
12/34/56
EX-10.34
from S-1/A 5 pages Ambrx, Inc. Executive Incentive Plan
12/34/56
EX-10.33
from S-1/A 12 pages Ambrx, Inc. Employee Stock Purchase Plan
12/34/56
EX-10.4
from S-1/A 3 pages Ambrx, Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.1
from S-1/A 15 pages Form of Indemnification Agreement
12/34/56
EX-10.32
from S-1 54 pages Certain Material (Indicated by an Asterisk) Has Been Omitted From This Document Pursuant to a Request for Confidential Treatment. the Omitted Material Has Been Filed Separately With the Securities and Exchange Commission. Co-Development and License Agreement Between Zhejiang Hisun Pharmaceutical Co., Ltd. and Ambrx, Inc. Dated as of April 10, 2014 Co-Development and License Agreement
12/34/56
EX-10.31
from S-1 3 pages Certain Material (Indicated by an Asterisk) Has Been Omitted From This Document Pursuant to a Request for Confidential Treatment. the Omitted Material Has Been Filed Separately With the Securities and Exchange Commission. Amendment No. 1 to Collaborative License Agreement
12/34/56